Fig. 4: HBVs and TLR2-L promote B-cell function.
From: Hepatitis B virus particles activate B cells through the TLR2–MyD88–mTOR axis
A FSC-A, MHC II, CD86, and TLR2 expression in HBV-stimulated B cells was measured by flow cytometry. B Antibodies, including IgG, IgM, and cytokine production, including IL-6, IL-10, and TNF-α, in HBV-stimulation, were measured by ELISA. (C) FSC-A, MHC II, and CD86 expression in TLR2-stimulated B cells were measured by flow cytometry. D Antibodies, including IgG and IgM, and cytokine production, including IL-6, IL-10, and TNF-α, in TLR2-L-stimulated B cells was measured by ELISA. Data are representative of three independent experiments. All data are presented as the mean ± SD (*p < 0.05; **p < 0.01; ***p < 0.001) according to t test (A, B) and one-way ANOVA (C, D).
